234 related articles for article (PubMed ID: 28286060)
1. A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.
Yamayoshi S; Uraki R; Ito M; Kiso M; Nakatsu S; Yasuhara A; Oishi K; Sasaki T; Ikuta K; Kawaoka Y
EBioMedicine; 2017 Mar; 17():182-191. PubMed ID: 28286060
[TBL] [Abstract][Full Text] [Related]
2. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J
Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849
[TBL] [Abstract][Full Text] [Related]
3. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
Yamayoshi S; Ito M; Uraki R; Sasaki T; Ikuta K; Kawaoka Y
J Infect; 2018 Feb; 76(2):177-185. PubMed ID: 29248585
[TBL] [Abstract][Full Text] [Related]
4. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
Yamayoshi S; Yasuhara A; Ito M; Uraki R; Kawaoka Y
J Clin Virol; 2018 Nov; 108():105-111. PubMed ID: 30292135
[TBL] [Abstract][Full Text] [Related]
5. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
6. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hemagglutinin targeted influenza virus neutralization.
Brandenburg B; Koudstaal W; Goudsmit J; Klaren V; Tang C; Bujny MV; Korse HJ; Kwaks T; Otterstrom JJ; Juraszek J; van Oijen AM; Vogels R; Friesen RH
PLoS One; 2013; 8(12):e80034. PubMed ID: 24348996
[TBL] [Abstract][Full Text] [Related]
9. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.
Wyrzucki A; Bianchi M; Kohler I; Steck M; Hangartner L
J Virol; 2015 Mar; 89(6):3136-44. PubMed ID: 25552718
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
Winarski KL; Tang J; Klenow L; Lee J; Coyle EM; Manischewitz J; Turner HL; Takeda K; Ward AB; Golding H; Khurana S
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15194-15199. PubMed ID: 31296560
[TBL] [Abstract][Full Text] [Related]
11. An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
Sano K; Saito S; Suzuki T; Kotani O; Ainai A; van Riet E; Tabata K; Saito K; Takahashi Y; Yokoyama M; Sato H; Maruno T; Usami K; Uchiyama S; Ogawa-Goto K; Hasegawa H
PLoS One; 2021; 16(1):e0245244. PubMed ID: 33412571
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of epitopes from influenza A virus hemagglutinin that induce broadly cross-reactive antibodies.
Li Y; Hu H; Qi Z; Sun J; Li Y; Feng Q; Guo C; Wang H; Zhao P; Liu Y; Zhao X; Wang G; Zhang H; Liu L; Hu J
Int J Mol Med; 2018 Mar; 41(3):1673-1682. PubMed ID: 29286160
[TBL] [Abstract][Full Text] [Related]
14. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin.
Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E
Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946
[TBL] [Abstract][Full Text] [Related]
15. Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
Manceur AP; Zou W; Marcil A; Paquet E; Gadoury C; Jaentschke B; Li X; Petiot E; Durocher Y; Baardsnes J; Rosa-Calatrava M; Ansorge S; Kamen AA
PLoS One; 2017; 12(6):e0180314. PubMed ID: 28662134
[TBL] [Abstract][Full Text] [Related]
16. Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.
Kotani O; Suzuki Y; Saito S; Ainai A; Ueno A; Hemmi T; Sano K; Tabata K; Yokoyama M; Suzuki T; Hasegawa H; Sato H
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578314
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.
Bächi T; Gerhard W; Yewdell JW
J Virol; 1985 Aug; 55(2):307-13. PubMed ID: 2410628
[TBL] [Abstract][Full Text] [Related]
18. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.
Wu Y; Cho M; Shore D; Song M; Choi J; Jiang T; Deng YQ; Bourgeois M; Almli L; Yang H; Chen LM; Shi Y; Qi J; Li A; Yi KS; Chang M; Bae JS; Lee H; Shin J; Stevens J; Hong S; Qin CF; Gao GF; Chang SJ; Donis RO
Nat Commun; 2015 Jul; 6():7708. PubMed ID: 26196962
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses.
Hu Z; Huang Y; Zhao J; Hu J; Hu S; Liu X
Protein Expr Purif; 2022 Apr; 192():106046. PubMed ID: 35007721
[TBL] [Abstract][Full Text] [Related]
20. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
